Ehsan Jabbarzadeh is a Venture Partner at IAG Capital Partners, an early-stage investment firm focused on life sciences and advanced computing. He is also a Full Professor of Chemical and Biomedical Engineering and Director of Engineering Entrepreneurship at the University of South Carolina. His professional career is represented by a Venn diagram of entrepreneurship, innovation, and academic leadership. As an entrepreneur, he co-founded and led Obsidio Inc, a venture-backed medical device company that pioneered a biomaterial technology to block blood flow with applications in hemorrhage control and interventional oncology. As an innovator, he directed a research laboratory focusing on biomaterials and stem cells. As an academic leader, he spearheaded the National Science Foundation (NSF) funded I-Corps Site as well as the Technology Innovation and Entrepreneurial Engineering programs. Ehsan’s credentials include a PhD in Chemical Engineering from Drexel University, Postdoctoral Fellowship in Bioengineering from the California Institute of Technology, and an MBA in Finance and Entrepreneurship from the University of Southern California, Marshall School of Business.